Unknown PHASE3 INTERVENTIONAL 2-arm NCT01382732

Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia

Carbetocin Versus Oxytocin for Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia: a Double Blind Randomized Controlled Trial

Sponsor: Saint Thomas Hospital, Panama

Conditions Postpartum Hemorrhage Severe Preeclampsia

Interventions Carbetocin Oxytocin

Updated 6 times since 2017 Last updated: Jan 1, 2015 Started: Jan 31, 2012 Primary completion: Dec 31, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01382732, this PHASE3 trial focuses on Postpartum Hemorrhage and Severe Preeclampsia and remains ongoing. Sponsored by Saint Thomas Hospital, Panama, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Saint Thomas Hospital, Panama

Data source: Saint Thomas Hospital, Panama

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Panama City, Panama